Background: Oocyte activation is driven by intracellular calcium (Ca ) oscillations induced by sperm-specific PLCζ, abrogation of which causes oocyte activation deficiency in humans. Clinical PLCζ investigations have been limited to severe male infertility conditions, while PLCζ levels and localisation patterns have yet to be associated with general sperm viability.
Materials And Methods: PLCζ profiles were examined within a general population of males attending a fertility clinic (65 patients; aged 29-53), examining PLCζ throughout various fractions of sperm viability. Male recruitment criteria required a minimum sperm count of 5 × 10 spermatozoa/mL, while all female patients included in this study yielded at least five oocytes for treatment. Sperm count, motility and semen volume were recorded according to standard WHO reference guidelines and correlated with PLCζ profiles examined via immunoblotting and immunofluorescence. Appropriate fertility treatments were performed following routine clinical standard operating protocols, and fertilisation success determined by successful observation of second polar body extrusion.
Results And Discussion: Four distinct PLCζ patterns were observed at the equatorial, acrosomal + equatorial regions of the sperm head, alongside a dispersed pattern, and a population of spermatozoa without any PLCζ. Acrosomal + equatorial PLCζ correlated most to sperm health, while dispersed PLCζ correlated to decreased sperm viability. Total levels of PLCζ exhibited significant correlations with sperm parameters. PLCζ variance corresponded to reduced sperm health, potentially underlying cases of male sub-fertility and increasing male age. Finally, significantly higher levels of PLCζ were exhibited by cases of fertilisation success, alongside higher proportions of Ac + Eq, and lower levels of dispersed PLCζ.
Conclusions: PLCζ potentially represents a biomarker of sperm health, and fertilisation capacity in general cases of patients seeking fertility treatment, and not just cases of repeated fertilisation. Further focused investigations are required with larger cohorts to examine the full clinical potential of PLCζ.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/andr.12796 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Gun Violence in Court.
J Law Med Ethics
December 2020
Abbe R. Gluck, J.D., is Professor of Law and the Founding Faculty Director of the Solomon Center for Health Law and Policy at Yale Law School and Professor of Medicine at Yale School of Medicine. Alexander Nabavi-Noori is a J.D. Candidate at Yale Law School, Class of 2021. Susan Wang is a J.D. Candidate at Yale Law School, Class of 2021.
Litigation cannot solve a public health crisis. But litigation can be an effective complementary tool to regulation by increasing the salience of a public health issue, eliciting closely guarded information to move public opinion, and prompting legislative action. From tobacco to opioids, litigants have successfully turned to courts for monetary relief, to initiate systemic change, and to hold industry accountableFor years, litigators have been trying to push firearm suits into their own litigation moment.
View Article and Find Full Text PDFStates' Rights, Gun Violence Litigation, and Tort Immunity.
J Law Med Ethics
December 2020
Hilary J. Higgins is a third-year law student at Yale Law School in New Haven, CT. She received her B.A. from Harvard College (2015) in Cambridge, MA. Jonathan E. Lowy, J.D., is Chief Counsel and Vice President of Legal at Brady United Against Gun Violence. He received his B.A. from Harvard College (1983) in Cambridge, MA, and his J.D. from the University of Virginia School of Law (1988) in Charlottesville, VA. Andrew J. Rising is a third-year law student at Yale Law School in New Haven, CT. He received his B.A. from the University of Michigan Gerald R. Ford School of Public Policy (2016) in Ann Arbor, MI.
The devastating toll of gun violence has given rise to hundreds of lawsuits seeking justice on behalf of victims and their families. A significant number of challenges against gun companies, however, are blocked by courts' broad reading of the Protection of Lawful Commerce in Arms Act (PLCAA) - a federal statute often interpreted to shield the gun industry from civil liability. This article reexamines PLCAA in light of the Supreme Court's recent federalism caselaw, which counsels courts to narrowly construe federal laws that could otherwise upset the balance of power between states and the federal government.
View Article and Find Full Text PDFAvailability of litigation as a public health tool for firearm injury prevention: comparison of guns, vaccines, and motor vehicles.
Am J Public Health
November 2007
Bloomberg School of Public Health and the Center for Gun Policy and Research, Johns Hopkins University, Baltimore, Md 21205, USA.
The Protection of Lawful Commerce in Arms Act (PLCAA), enacted in 2005, grants the firearm industry broad immunity from liability. The PLCAA not only prevents most people from receiving compensation for their firearm-related injuries, it erodes litigation's ability to serve its public health role of providing manufacturers with a financial incentive to make their products safer. When the viability of the vaccine industry was threatened in the 1980s, Congress provided limited protection from liability and also established the Vaccine Injury Compensation Program.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!